Table 2 Clinical characteristics along with the type of solid malignancy in patients
Characteristic | Frequency | Percent (%) |
|---|---|---|
Underlying tumor type | ||
Breast | 13 | 13.5 |
Urinary tract1 | 10 | 10.4 |
Colorectal | 9 | 9.4 |
Gynecological2 | 8 | 8.3 |
Pancreatic | 8 | 8.3 |
Hepatobiliary | 7 | 7.3 |
Lung | 7 | 7.3 |
Gastric | 7 | 7.3 |
Sarcoma | 6 | 6.3 |
Prostate | 5 | 5.2 |
Small bowel | 5 | 5.2 |
Others3 | 4 | 4.2 |
Esophageal | 3 | 3.1 |
Head and neck4 | 3 | 3.1 |
Testicular | 1 | 1 |
Metastatic disease | 40 | 41.7 |
Comorbidities | 54 | 56.3 |
Neutropenic fever | 16 | 13.8 |
Previous chemotherapy (during 1 month) | 75 | 64.7 |
Previous radiotherapy (during 1 month) | 12 | 10.3 |
Previous invasive procedure (during 10 days) | 62 | 53.4 |
Recent medications (1 month) | ||
Corticosteroid therapy | 17 | 14.7 |
Immunosuppressive medications* | 6 | 5.2 |
Hormonal therapy | 9 | 7.8 |
Previous antimicrobial therapy | 67 | 57.8 |
Source of BSI | ||
Unknown | 45 | 38.8 |
Catheter related5 | 42 | 36.2 |
Skin and soft tissue | 7 | 6 |
Respiratory tract infections | 7 | 6 |
Cholangitis | 7 | 6 |
Urinary tract | 6 | 5.2 |
Other sites6 | 2 | 1.7 |
Presence of central line | 37 | 31.9 |
NO. of BSI | ||
One episode | 79 | 82.3 |
Two episodes | 14 | 14.6 |
Multi-episodes | 3 | 3.1 |